CAS No 920509-32-6 MGL-3196；RESMETIROM Pharmaceutical Intermediates
Product detail
MGL-3196, also known as RESMETIROM, is a novel selective thyroid hormone receptor β (THR-β) agonist that shows great potential in the treatment of metabolic disorders, especially non-alcoholic fatty liver disease (NAFLD) and dyslipidemia. By selectively activating THR-β, MGL-3196 enhances lipid metabolism and improves liver function without the adverse side effects associated with non-selective thyroid hormone therapy.
This makes it a valuable candidate for the development of new therapeutic strategies aimed at improving metabolic health.
Physical and chemical properties
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, slightly soluble in water, and easy to prepare into various dosage forms.
- Stability: MGL-3196 exhibits good stability under recommended storage conditions, ensuring longer shelf life and reliability in therapeutic applications.
These properties make MGL-3196 suitable for formulation of various drug products, including tablets and capsules.
The advantages of using MGL-3196 (RESMETIROM) in drug formulations are many:
- Targeted Action: MGL-3196 selectively targets thyroid hormone receptor beta, providing a targeted therapeutic approach that enhances lipid metabolism while minimizing side effects.
- Improves Metabolic Health: Clinical studies have shown that MGL-3196 can significantly reduce liver fat content and improve lipid profiles, making it a promising treatment for patients with NAFLD and dyslipidemia.
- Regulatory Compliance: Our MGL-3196 is manufactured in accordance with international pharmaceutical standards, ensuring that it meets the stringent requirements set by health authorities.
- Research and Development Support: We provide comprehensive technical support and documentation to assist researchers and pharmaceutical companies in the development process.
As a production and trading integrated factory, we are committed to providing customers with high-quality MGL-3196 (RESMETIROM). Our dedication to quality is reflected in our advanced manufacturing process and strict quality control measures.
- Expertise: Our dedicated team of professionals is dedicated to research and development, ensuring we are always at the forefront of pharmaceutical innovation.
- Customer-centric approach: We prioritize our customers' needs, providing customized solutions and responsive customer service to support their specific requirements.
- Sustainability: We are committed to using sustainable practices in our manufacturing process, ensuring minimal impact on the environment while maintaining product quality.
In summary, MGL-3196 (RESMETIROM) is an important pharmaceutical ingredient that offers numerous benefits for treating metabolic disorders. With our comprehensive production capabilities, high quality standards, and commitment to customer satisfaction, we are your ideal partner in the pharmaceutical industry.
Choose our MGL-3196 (RESMETIROM) for your formulation and experience the difference in quality and efficacy. For inquiries or to place an order, please contact us today!